Clinical Trial Update: Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating fruquintinib plus camrelizumab with hepatic arterial infusion chemotherapy in non-MSI-H advanced colorectal cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING